In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Marks the World Head & Neck Cancer Day at the OCTF Conference
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
This transformation will enable GE HealthCare to build a strong foundation for business growth
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Subscribe To Our Newsletter & Stay Updated
